Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics

International Journal of Cancer

Volumn 130, Issue 9, 2012, Pages 2103-2110

  Verkooijen, Helena M ^a   Hartman, Mikael ^a,b,c   Usel, Massimo ^d   Benhamou, Simone ^e,f   Neyroud Caspar, Isabelle ^d   Czene, Kamila ^c   Vlastos, Georges ^g   Chappuis, Pierre O ^g   Bouchardy, Christine ^d   Rapiti, Elisabetta ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c KAROLINSKA INSTITUTE   (Sweden)

^d GENEVA CANCER REGISTRY   (Switzerland)

^e FONDATION JEAN DAUSSET CEPH   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

breast cancer; epidemiology; heritability; prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; HAZARD RATIO; HERITABILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; RELATIVE; SEX DIFFERENCE; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; SWITZERLAND;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MOTHERS; NEOPLASM STAGING; NUCLEAR FAMILY; PROGNOSIS; SIBLINGS; SURVIVAL ANALYSIS; SWITZERLAND;

EID: 84857501972     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26206     Document Type: Article

References (30)

1. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R,. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-91.
2. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC,. Early breast cancer. Lancet 2009; 373: 1463-79.
3. Hartman M, Lindstrom L, Dickman PW, Adami HO, Hall P, Czene K,. Is breast cancer prognosis inherited? Breast Cancer Res 2007; 9: R39.
4. Lindstrom LS, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K,. Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol 2007; 8: 1001-6.
5. Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW,. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. Breast Cancer Res 2009; 11: R75.
6. Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, Easton DF, Pharoah PP,. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 2002; 62: 3052-7.
7. Bouchardy C,. Switzerland, Geneva. In:, Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, eds. Cancer incidence in five continents, vol. 9. Lyon: International Agency for Research on Cancer, 2007. 369-70.
8. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, eds. ICD-O international classification of diseases for oncology, 3rd edn. Geneva: World Health Organization, 2000.
9. Verkooijen HM, Fioretta G, Chappuis PO, Vlastos G, Sappino AP, Benhamou S, Bouchardy C,. Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol 2004; 15: 350-3.
10. Office Fédéral de la Statistique (OFS), Mdlp, eds. Classifications des professions, des situations dans la professions, des classes économiques. Berne: OFS, 1979.
11. Leete R, Fox AJ,. Registrar General's social classes: origins and uses. Population Trends 1977; 8: 1-7.
12. Hunter KW, Alsarraj J,. Gene expression profiles and breast cancer metastasis: a genetic perspective. Clin Exp Metastasis 2009; 26: 497-503.
13. Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, Hunter KW,. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 1998; 77: 640-4.
14. Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes L, Rowe WL, Zhang J, Ambs S, Lowy DR, Anton-Culver H, et al. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 2007; 3: e214.
15. Hunter KW, Crawford NP,. Germ line polymorphism in metastatic progression. Cancer Res 2006; 66: 1251-4.
16. Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, Rouse J, Welch DR,. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 2001; 61: 8866-72.
17. Lukes L, Crawford NP, Walker R, Hunter KW,. The origins of breast cancer prognostic gene expression profiles. Cancer Res 2009; 69: 310-18.
18. Whittemore AS, Stearman B, Venne V, Halpern J, Felberg A, McGuire V, Daly M, Buys SS,. No evidence of familial correlation in breast cancer metastasis. Breast Cancer Res Treat 2009; 118: 575-81.
19. Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK,. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 2008; 26: 4282-8.
20. Foulkes WD, Rosenblatt J, Chappuis PO,. The contribution of inherited factors to the clinicopathological features and behavior of breast cancer. J Mammary Gland Biol Neoplasia 2001; 6: 453-65.
21. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, Masson G, Jakobsdottir M, Thorlacius S, Helgason A, Aben KK, Strobbe LJ, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007; 39: 865-9.
22. Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Arias JI, Menendez P, et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 2010; 102: 650-62.
23. Higgins MJ, Stearns V,. CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance. Curr Oncol Rep 2010; 12: 7-15.
24. O'Malley FP, Chia S, Tu D, Shepherd LE, Levine MN, Bramwell VH, Andrulis IL, Pritchard KI,. Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. J Natl Cancer Inst 2009; 101: 644-50.
25. Fagerholm R, Hofstetter B, Tommiska J, Aaltonen K, Vrtel R, Syrjakoski K, Kallioniemi A, Kilpivaara O, Mannermaa A, Kosma VM, Uusitupa M, Eskelinen M, et al. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet 2008; 40: 844-53.
26. Gor PP, Su HI, Gray RJ, Gimotty PA, Horn M, Aplenc R, Vaughan WP, Tallman MS, Rebbeck TR, DeMichele A,. Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast Cancer Res 2010; 12: R26.
27. Bouchardy C, Verkooijen HM, Fioretta G,. Social class is an important and independent prognostic factor of breast cancer mortality. Int J Cancer 2006; 119: 1145-51.
28. Dal Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, Vercelli M, Falcini F, Franceschi S,. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 2008; 123: 2188-94.
29. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA,. Physical activity and survival after breast cancer diagnosis. JAMA 2005; 293: 2479-86.
30. Emaus A, Veierod MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I,. Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat 2010; 121: 651-60.